EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Cardamonin suppresses mTORC1/SREBP1 through reducing Raptor and inhibits de novo lipogenesis in ovarian cancer

Peiguang Niu iD, Danyun Li, Huajiao Chen iD, Yanting Zhu, Jintuo Zhou, Jinhua Zhang, Ying Liu

PLOS One · 2025

DOI: 10.1371/journal.pone.0322733 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS One, 2025. Verfasst von Peiguang Niu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Fujian Maternity and Child Health Hospital, College of Clinical Medicine for Obstetrics and Gynecology and Pediatrics, Fujian…. Hauptthemen laut MEDLINE: Ovarian Neoplasms, Lipogenesis, Mechanistic Target of Rapamycin Complex 1, Sterol Regulatory Element Binding Protein 1. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Science Foundation of Fujian Province, Joint Funds for the Innovation of Science and Technology of Fujian Province, Fujian Provincial Health Technology Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Metabolic reprogramming is a hallmark of cancer and de novo lipogenesis (DNL) accelerates the progression of ovarian cancer. In this study, we investigated the effects of cardamonin, a natural compound potential to suppress various malignancies, on the lipid anabolism in ovarian cancer. Cell proliferation was assessed using CCK-8 and clone formation assay. Cell apoptosis was detected by flow cytometry with Annexin V-FITC/PI staining and mitochondrial membrane potential (MMP) was measured with JC-10 probe. Free fatty acids (FFA) was measured by fluorescence using acyl-CoA oxidation and carnitine palmitoyl transferase-1 (CPT-1) activity was analyzed by spectrophotometric assay using palmitoyl-CoA and DTNB (5,5’-dithio-bis-(2-nitrobenzoic acid)) reaction. mRNA expression was measured by Quantitative Real-Time PCR. Protein expression was analyzed through western blotting and immunofluorescence. Raptor was knocked down by shRNA and Raptor was overexpressed by lentiviral transfection. The antitumor effect of cardamonin was evaluated using a xenotransplantation tumor bearing mouse model. Cardamonin suppressed the cell proliferation, induced cell apoptosis and triggered mitochondrial damage in ovarian cancer cells. Cardamonin inhibited the protein expression of sterol regulatory element binding protein 1 (SREBP1) and its downstream lipogenic enzymes and decreased FFA content and CPT-1 activity. Additionally, cardamonin inhibited the activation of mechanistic target of rapamycin complex 1 (mTORC1) and expression of regulatory-associated protein of mTOR (Raptor). Raptor knockdown abolished the inhibitory effect of cardamonin on mTORC1 and SREBP1. Furthermore, cardamonin inhibited mTORC1 activation and lipogenic proteins expression induced by Raptor overexpression. Cardamonin reduced the tumor growth and fatty acid synthase of the tumors, as evidenced by decreased expression of Ki-67 and FASN. It suggests that cardamonin suppresses mTORC1/SREBP1 through reducing the protein level of Raptor and inhibits DNL of ovarian cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Ovarian NeoplasmsLipogenesisMechanistic Target of Rapamycin Complex 1Sterol Regulatory Element Binding Protein 1ChalconesRegulatory-Associated Protein of mTORFemaleHumansAnimalsCell Line, TumorMiceApoptosisCell ProliferationXenograft Model Antitumor AssaysMice, NudeGene Expression Regulation, NeoplasticCarnitine O-Palmitoyltransferase

Substanzen

Mechanistic Target of Rapamycin Complex 1cardamoninSterol Regulatory Element Binding Protein 1ChalconesRegulatory-Associated Protein of mTORSREBF1 protein, humanRPTOR protein, humanCarnitine O-Palmitoyltransferase

Autor:innen und Institutionen

  • Department of Pharmacy, Fujian Maternity and Child Health Hospital, College of Clinical Medicine for Obstetrics and Gynecology and Pediatrics, Fujian Medical University, Fuzhou, Fujian, China.
  • Fujian Key Laboratory of Women and Children's Critical Diseases Research [Fujian Maternity and Child Health Hospital (Fujian Women and Children's Hospital)], Fujian Maternity and Child Health Hospital, Fuzhou, Fujian, C…

ORCID-Profile: Peiguang Niu, Huajiao Chen

Förderung

  • Natural Science Foundation of Fujian Province
  • Joint Funds for the Innovation of Science and Technology of Fujian Province
  • Fujian Provincial Health Technology Project
  • Startup Fund for scientific research, Fujian Medical University

Zitieren

APA

Niu, P., Li, D., Chen, H., Zhu, Y., Zhou, J., Zhang, J., & Liu, Y. (2025). Cardamonin suppresses mTORC1/SREBP1 through reducing Raptor and inhibits de novo lipogenesis in ovarian cancer. PLOS One. https://doi.org/10.1371/journal.pone.0322733

Vancouver

Niu P, Li D, Chen H, Zhu Y, Zhou J, Zhang J, et al. Cardamonin suppresses mTORC1/SREBP1 through reducing Raptor and inhibits de novo lipogenesis in ovarian cancer. PLOS One. 2025. doi:10.1371/journal.pone.0322733

BibTeX
@article{Niu2025,
  author = {Niu, Peiguang and Li, Danyun and Chen, Huajiao and Zhu, Yanting and Zhou, Jintuo and Zhang, Jinhua and Liu, Ying},
  title = {Cardamonin suppresses mTORC1/SREBP1 through reducing Raptor and inhibits de novo lipogenesis in ovarian cancer},
  journal = {PLOS One},
  year = {2025},
  doi = {10.1371/journal.pone.0322733}
}
Kostenlos starten →